1-6 of 6
incretin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes

Richard E. Pratley, Eugenio Cersosimo
Journal: Clinical Diabetes
Clin Diabetes 2017;35(3):141–153
https://doi.org/10.2337/cd16-0063
Published: 01 July 2017
View article titled, Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes
Open the PDF for Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes in another window
Journal Articles

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies

Charles F. Shaefer, Jr.
Journal: Clinical Diabetes
Clin Diabetes 2016;34(2):81–85
https://doi.org/10.2337/diaclin.34.2.81
Published: 01 April 2016
View article titled, Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
Open the PDF for Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies in another window
Journal Articles

Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence

Timothy Reid, MD
Journal: Clinical Diabetes
Clin Diabetes 2012;30(1):3–12
https://doi.org/10.2337/diaclin.30.1.3
Published: 01 January 2012
View article titled, Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence
Open the PDF for Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence in another window
Journal Articles

Change as a Constant

Tom Elasy, MD, MPH
Journal: Clinical Diabetes
Clin Diabetes 2008;26(2):49–50
https://doi.org/10.2337/diaclin.26.2.49
Published: 01 April 2008
View article titled, Change as a Constant
Open the PDF for Change as a Constant in another window
Journal Articles

Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use

John R. White, Jr., PA, PharmD
Journal: Clinical Diabetes
Clin Diabetes 2008;26(2):53–57
https://doi.org/10.2337/diaclin.26.2.53
Published: 01 April 2008
View article titled, Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use
Open the PDF for Dipeptidyl Peptidase-IV Inhibitors: Pharmacological Profile and Clinical Use in another window
Journal Articles

Diabetes Treatment, Part 3: Insulin and Incretins

Michael J. Fowler, MD
Journal: Clinical Diabetes
Clin Diabetes 2008;26(1):35–39
https://doi.org/10.2337/diaclin.26.1.35
Published: 01 January 2008
View article titled, Diabetes Treatment, Part 3: Insulin and Incretins
Open the PDF for Diabetes Treatment, Part 3: Insulin and Incretins in another window